Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model
Authors:
- Ditte Olsen LützhøftDLDitte Olsen Lützhøft
- Tim SiniojaTSTim Sinioja
- Berit Ø. ChristoffersenBCBerit Ø. Christoffersen
- Rasmus Riemer JakobsenRJRasmus Riemer Jakobsen
- Dawei GengDGDawei Geng
- Hajar Fauzan Bin AhmadHAHajar Fauzan Bin Ahmad
- Ellen Marie StraarupESEllen Marie Straarup
- Karen-Margrethe PedersenKPKaren-Margrethe Pedersen
- Witold KotWitold Kot
- Henrik Duelund PedersenHPHenrik Duelund Pedersen
- Susanna CireraSCSusanna Cirera
- Tuulia HyötyläinenTuulia Hyötyläinen
Open Access
- 1 December 2022
- journal article
- research article
- Published by Springer Nature in BMC Microbiology
- Vol. 22 (1) , 1-14
Abstract
Background: Gut microbiota dysbiosis is associated with the development of non-alcoholic steatohepatitis (NASH) through modulation of gut barrier, inflammation, lipid metabolism, bile acid signaling and short-chain fatty acid production. The aim of this study was to describe the impact of a choline-deficient amino acid defined high fat diet (CDAHFD) on the gut microbiota in a male Göttingen Minipig model and on selected pathways implicated in the development of NASH. Results: Eight weeks of CDAHFD resulted in a significantly altered colon microbiota mainly driven by the bacterial families Lachnospiraceae and Enterobacteriaceae, being decreased and increased in relative abundance, respectively. Metabolomics analysis revealed that CDAHFD decreased colon content of short-chain fatty acid and increased colonic pH. In addition, serum levels of the microbially produced metabolite imidazole propionate were significantly elevated as a consequence of CDAHFD feeding. Hepatic gene expression analysis showed upregulation of mechanistic target of rapamycin (mTOR) and Ras Homolog, MTORC1 binding in addition to downregulation of insulin receptor substrate 1, insulin receptor substrate 2 and the glucagon receptor in CDAHFD fed minipigs. Further, the consequences of CDAHFD feeding were associated with increased levels of circulating cholesterol, bile acids, and glucagon but not total amino acids. Conclusions: Our results indicate imidazole propionate as a new potentially relevant factor in relation to NASH and discuss the possible implication of gut microbiota dysbiosis in the development of NASH. In addition, the study emphasizes the need for considering the gut microbiota and its products when developing translational animal models for NASH.Keywords
This publication has 51 references indexed in Scilit:
- Urocanate reductase: identification of a novel anaerobic respiratory pathway in Shewanella oneidensisMR‐1Molecular Microbiology, 2012
- Associating microbiome composition with environmental covariates using generalized UniFrac distancesBioinformatics, 2012
- Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progressionCurrent Opinion in Gastroenterology, 2012
- Relevance of protein fermentation to gut healthMolecular Nutrition & Food Research, 2011
- Assessment of gastrointestinal pH, fluid and lymphoid tissue in the guinea pig, rabbit and pig, and implications for their use in drug developmentEuropean Journal of Pharmaceutical Sciences, 2011
- High‐fat diet‐induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exerciseThe Journal of Physiology, 2007
- Glucagon and cAMP inhibit cholesterol 7α‐hydroxylase (CYP7a1) gene expression in human hepatocytesHepatology, 2005
- VEGAN, a package of R functions for community ecologyJournal of Vegetation Science, 2003
- Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugsGut, 2001
- The Effect of Food Preservatives on pH Homeostasis in Escherichia coliMicrobiology, 1984